Back
AFW
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
Applyflow Limited
🇦🇺 ASX
📈 HIGH PRICE GROWTH
🎥 MEDIA
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 13.33%
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
1
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Applyflow Ltd. engages in the development of Talent-On-Demand cloud based platform. The company is headquartered in Sydney, New South Wales. The company went IPO on 2010-11-30. The firm is focused on human resource management with an enhanced single offering to the recruitment market. Its three geographical operating segments include Asia-Pacific (APAC); Europe, the Middle East and Africa (EMEA); and the Americas. The Company’s products and services include recruitment Website, career websites and employer branding, job board software, and recruitment marketing services. Its recruitment marketing services include research and discovery, branding, visual design, copywriting, Website development, custom functionality, analytics and event tracking, Web interactions, integrations, email campaigns, live chat integration, and job adverting. Its subsidiaries include Applypay Pty Ltd, JXT Global (US), Inc, JXT Global (UK) Limited, and JXT Australia Pty Ltd.
📈 Performance
Price History
-9.09%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.40
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in AFW
0
📊 Total Capital Earnings
$4K
🔃 Average investment frequency
19 weeks
💵 Average investment amount
$1,052
⏰ Last time a customer invested in AFW
1086 days
AFW investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in AFW also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
8.55%
📊 Share price
$111.35 AUD
🇦🇺 AUSTRALIA
💸 FINANCIALS
🧱 MATERIALS
📈 HIGH PRICE GROWTH
⛳️ DIVERSIFIED
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
7.55%
📊 Share price
$74.38 AUD
⛳️ DIVERSIFIED
🌏 GLOBAL
ASIA.AX was created on 2018-09-18 by BetaShares. The fund's investment portfolio concentrates primarily on information technology equity. The investment objective of the BetaShares Asia Technology Tigers ETF is to provide an investment return that aims to track the performance of the Solactive Asia ex-Japan Technology & Internet Tigers Index (the Index), before taking into account fees and expenses.
🙌 Performance (5Yr p.a)
8.52%
📊 Share price
$14.79 AUD
🇦🇺 EX AUSTRALIA
📈 HIGH PRICE GROWTH
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
17.39%
📊 Share price
$152.67 AUD
🌏 GLOBAL
🤖 TECHNOLOGY
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialization of immunotherapies against cancer. The company is headquartered in Sydney, New South Wales. The company is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs.
🙌 Performance (5Yr p.a)
132.68%
📊 Share price
$0.43 AUD
🧬 BIOTECHNOLOGY
Want more shares? Try these...
